| Financial Year |
March 31 2023 |
| Monetary Funds |
80,248,318,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,026,000.00 |
| Accounts Receivable |
65,339,024,000.00 |
| Advances to Suppliers |
698,360,000.00 |
| Other Receivables |
1,153,116,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
74,633,908,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
10,000,000.00 |
| Other Current Assets |
1,989,539,000.00 |
| Total Current Assets |
224,332,797,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,488,334,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
15,944,644,000.00 |
| Under-construction Projects |
791,864,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
449,118,000.00 |
| R&D expenses |
-- |
| Goodwill |
310,153,000.00 |
| Long-Term Deferred and Prepaid Expenses |
1,780,682,000.00 |
| Deferred Income Tax Assets |
1,023,537,000.00 |
| Other Non-Current Assets |
978,745,000.00 |
| Sub-Total of Non-Current Assets |
33,279,208,000.00 |
| Total Assets |
257,612,005,000.00 |
| Short-Term Loans |
40,995,873,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
54,001,409,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,993,089,000.00 |
| Taxes Payable |
1,232,218,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,719,284,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,155,127,000.00 |
| Other Current Liabilities |
737,844,000.00 |
| Sub-Total of Current Liabilities |
119,054,347,000.00 |
| Long-term Loans |
4,036,392,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
492,948,000.00 |
| Deferred Income Tax Liabilities |
162,750,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,034,118,000.00 |
| Total Liabilities |
125,088,465,000.00 |
| Paid-In Capital(Or Share Stock) |
19,862,894,000.00 |
| Capital Surplus |
28,544,667,000.00 |
| Surplus Reserve |
3,809,459,000.00 |
| LESS:Treasury Stock |
2,207,903,000.00 |
| Undistributed Profits |
81,062,424,000.00 |
| Minority Stockholder's Interest |
354,038,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
132,169,502,000.00 |
| Owner's Equity（Stockholder's Equity） |
132,523,540,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
257,612,005,000.00 |
